Ets-1 targeted by MicroRNA-221 regulates angiotensin II-induced renal fibroblast activation and fibrosis

Cellular Physiology and Biochemistry

Volumn 34, Issue 4, 2014, Pages 1063-1074

  Di, Jia ^a,b   Jiang, Lei ^a   Zhou, Yang ^a   Cao, Hongdi ^a   Fang, Li ^a   Wen, Ping ^a   Li, Xiurong ^b   Dai, Chunsun ^a   Yang, Junwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Angiotensin II; Fibroblast; MicroRNA; Renal fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; FIBRONECTIN; MICRORNA 221; TRANSCRIPTION FACTOR ETS 1; MICRORNA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROBLAST; GENE CONTROL; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY FIBROSIS; MALE; MOUSE; MTT ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; FIBROSIS; GENE EXPRESSION; GENETICS; KIDNEY; KIDNEY DISEASE; METABOLISM;

ANGIOTENSIN II; ANIMALS; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FIBROBLASTS; FIBRONECTINS; FIBROSIS; GENE EXPRESSION; KIDNEY; KIDNEY DISEASES; MICE; MICE, INBRED BALB C; MICRORNAS; PROTO-ONCOGENE PROTEIN C-ETS-1; RATS; UP-REGULATION;

EID: 84908658789     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366321     Document Type: Article

References (36)

1. McFarlane SI, McCullough PA, Sowers JR, Soe K, Chen SC, Li S, Vassalotti JA, Stevens LA, Salifu MO, Kurella Tamura M, BombackAS, Norris KC, Collins AJ, Bakris GL, Whaley-Connell AT: Comparison of the ckd epidemiology collaboration (ckd-epi) and modification of diet in renal disease (mdrd) study equations: Prevalence of and risk factors for diabetes mellitus in ckd in the kidney early evaluation program (keep). Am J Kidney Dis 2011;57:S24-31.
2. Kovesdy CP, Kalantar-Zadeh K: Enter the dragon: A Chinese epidemic of chronic kidney disease? Lancet 2012;379:783-785.
3. Wynn TA, Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med 2012;18:1028-1040.
4. Strutz F, Zeisberg M: Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006;17:2992-2998.
5. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011;7:684-696.
6. Hu K, Lin L, Tan X, Yang J, Bu G, Mars WM, Liu Y: Tpa protects renal interstitial fibroblasts and myofibroblasts from apoptosis. J Am Soc Nephrol 2008;19:503-514.
7. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010;6:643-656.
8. Hinz B: The myofibroblast: Paradigm for a mechanically active cell. J Biomech 2010;43:146-155.
9. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y: Wnt/beta-catenin signaling promotes renal interstitial fibrosis. ] Am Soc Nephrol 2009;20:765-776.
10. Xia Y, Entman ML, Wang Y: Critical role of cxcll6 in hypertensive kidney injury and fibrosis. Hypertension 2013;62:1129-1137.
11. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin ii and renal fibrosis. Hypertension 2001;38:635-638.
12. Russell L, Garrett-Sinha LA: Transcription factor ets-1 in cytokine and chemokine gene regulation. Cytokine 2010;51:217-226.
13. Razzaque MS, Naito T, Taguchi T: Proto-oncogene ets-1 and the kidney. Nephron 2001;89:1-4.
14. Oikawa T, Yamada T: Molecular biology of the ets family of transcription factors. Gene 2003;303:11-34.
15. Ni W, Zhan Y, He H, Maynard E, Balschi JA, Oettgen P: Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin ii. Circ Res 2007;101:985-994.
16. Ebrahimian X Li MW, Lemarie CA, Simeone SM, Pagano PJ, Gaestel M, Paradis P, Wassmann S, Schiffrin EL: Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin ii-induced inflammation and hypertension: Regulation of oxidative stress. Hypertension 2011;57:245-254.
17. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
18. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y: Endothelial enriched micrornas regulate angiotensin ii-induced endothelial inflammation and migration. Atherosclerosis 2011;215:286-293.
19. Ye X, Bai W, Zhu H, Zhang X, Chen Y, Wang L, Yang A, Jia L: Mir-221 promotes trastuzumab-resistance and metastasis in her2-positive breast cancers by targeting pten. BMB Rep 201;47:268-273.
20. Sun T, WangX, He HH, Sweeney CJ, Liu SX, Brown M, Balk S, Lee GS, Kantoff PW: Mir-221 promotes the development of androgen independence in prostate cancer cells via downregulation of hectd2 and rabla. Oncogene 2014;33:2790-2800.
21. RongM, ChenG, DangY: Increased mir-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer 2013;13:21.
22. Lupini L, Bassi C, Ferracin M, Bartonicek N, DAbundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, Corrales FJ, Enright AJ, Sabbioni S, Negrini M: Mir-221 affects multiple cancer pathways by modulating the level of hundreds messenger rnas. Front Genet 2013;4:64.
23. Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouye S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C: Increased circulating mir-21 levels are associated with kidney fibrosis. PLoSOne2013;8:e58014.
24. Yang Z, Xiaohua W Lei J, Ruoyun T, Mingxia X, Weichun H, Li F, Ping W Junwei Y: Uric acid increases fibronectin synthesis through up regulation of lysyl oxidase expression in rat renal tubular epithelial cells. Am J Physiol Renal Physiol 2010;299:F336-346.
25. Meerson A, Traurig M, Ossowski V, Fleming JM, Mullins M, Baier LJ: Human adipose microrna-221 is upregulated in obesity and affects fat metabolism downstream of leptinand tnf-alpha. Diabetologia 2013;56:1971-1979.
26. Mezzano SA, Aros CA, Droguett A, Burgos ME, Ardiles LG, Flores CA, Carpio D, Vio CP, Ruiz-Ortega M, Egido J: Renal angiotensin ii up-regulation and myofibroblast activation in human membranous nephropathy. Kidney Int 2003:S39-45.
27. Macconi D: Targeting the renin angiotensin system for remission/regression of chronic kidney disease. Histol Histopathol 2010;25:655-668.
28. Ruster C, Wolf G: Angiotensin ii as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011;22:1189-1199.
29. Naito T, Razzaque MS, Nazneen A, Liu D, Nihei H, Koji T, Taguchi T: Renal expression of the ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol 2000;11:2243-2255.
30. Kanazawa A, Tsukada S, Sekine A, Tsunoda T, Takahashi A, Kashiwagi A, Tanaka Y, Babazono T, Matsuda M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakamura Y, Maeda S: Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5b (wnt5b) with type 2 diabetes. Am JHumGenet2004;75:832-843.
31. Puri S, Rodova M, Islam MR, Magenheimer BS, Maser RL, Calvet JP: Ets factors regulate the polycystic kidney disease-1 promoter. Biochem Biophys Res Commun 2006;342:1005-1013.
32. Raffetseder U, Wernert N, Ostendorf T, van Roeyen C, Rauen T, Behrens P, Floege J, Mertens PR: Mesangial cell expression of proto-oncogene ets-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int 2004;66:622-632.
33. Liu DX, LiuXM, Su Y, Zhang XJ: Renal expression of proto-oncogene ets-1 on matrix remodeling in experimental diabetic nephropathy. Acta Histochem 2011;113:527-533.
34. Feng W, Chumley P, Hua P, Rezonzew G, Jaimes D, Duckworth MW, Xing D, Jaimes EA: Role of the transcription factor erythroblastosis virus e26 oncogen homolog-1 (ets-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin ii. Hypertension 2012;60:1226-1233.
35. Jiang L, Qiu W, Zhou Y, Wen P, Fang L, Cao H, Zen K, He W, Zhang C, Dai C, Yang J: A microrna-30e/ mitochondrial uncoupling protein 2 axis mediates tgf-betal-induced tubular epithelial cell extracellular matrix production and kidney fibrosis. Kidney Int 2013;84:285-296.
36. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J: The mir-200 family regulates tgf-betal-induced renal tubular epithelial to mesenchymal transition through smad pathway by targeting zebl and zeb2 expression. Am J Physiol Renal Physiol 2012;302:F369-379.